A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : HCV

Search Conditions:
Search Keyword : HCV
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: HCV
Appearance Frequency: 33940 time(s)
Long forms: 90

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
hepatitis C virus
(33384 times)
Gastroenterology
(7918 times)
HBV (3244 times)
HCC (2213 times)
HIV (2157 times)
0 [Pandemic of hepatitis C virus infection].
hepatitis C virus infection
(173 times)
Gastroenterology
(42 times)
IFN (15 times)
HCC (14 times)
SVR (14 times)
0 [Extrahepatic manifestations of HCV infection].
HCVcc
(115 times)
Virology
(45 times)
HCVpp (28 times)
SR-BI (10 times)
siRNA (7 times)
2006 Hepatitis C virus entry: potential receptors and their biological functions.
hog cholera virus
(96 times)
Veterinary Medicine
(44 times)
BVDV (29 times)
BDV (9 times)
mAbs (9 times)
1968 The purification and concentration of hog cholera virus.
human coronavirus
(32 times)
Virology
(17 times)
BCV (5 times)
HEV (4 times)
HI (3 times)
1981 Two antigenic groups of human coronaviruses detected by using enzyme-linked immunosorbent assay.
hippocampal volume
(22 times)
Neurology
(11 times)
MRI (7 times)
HS (4 times)
ICV (3 times)
1997 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
HCV-Ab
(7 times)
Gastroenterology
(2 times)
HBsAg (2 times)
HIV (2 times)
ART (1 time)
1996 [Familial transmission of hepatitis C virus].
human calicivirus
(6 times)
Microbiology
(3 times)
ELISA (1 time)
ELISAs (1 time)
IEM (1 time)
1985 Humoral immunity in infants with gastroenteritis caused by human calicivirus.
hepatitis C virus antibody
(4 times)
Medicine
(1 time)
CHD (1 time)
CV (1 time)
CVD (1 time)
1990 [Hepatitis C virus antibodies (HCV) in patients treated with chronic hemodialysis].
10  HC virus
(3 times)
Veterinary Medicine
(2 times)
HC (2 times)
BVDV (1 time)
HCC (1 time)
1976 Natural infection of pigs with bovine viral diarrhea virus and its differential diagnosis from hog cholera.
11  HCV infection
(3 times)
Biomedical Research
(1 time)
alpha-IFN (1 time)
SHF (1 time)
TBARS (1 time)
2001 [Cryoglobulinemia and hepatitis C virus infection].
12  hepatitis C virus genome
(3 times)
Molecular Biology
(1 time)
RFLP (1 time)
1996 Improved amplification system for detection of hepatitis C virus genome that simultaneously differentiates viral genotypes.
13  hepatitis virus type C
(3 times)
Medicine
(1 time)
CH (1 time)
DM (1 time)
HBs (1 time)
1994 A seroepidemiological study of hepatitis C virus (HCV) in an area with a high prevalence of chronic liver disease in the Kyushu district of Japan.
14  HCV group
(2 times)
Gastroenterology
(1 time)
HBV (2 times)
HCC (2 times)
AFP (1 time)
2007 Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
15  HCV-positive group
(2 times)
Tooth Diseases
(1 time)
OLP (2 times)
ICC (1 time)
2005 Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.
16  HCVser
(2 times)
Clinical Laboratory Techniques
(1 time)
HLCs (1 time)
iPSCs (1 time)
MSCs (1 time)
2011 Intracellular delivery of serum-derived hepatitis C virus.
17  hepatitis C virus chronic infection
(2 times)
Allergy and Immunology
(2 times)
AT (1 time)
HCVrA (1 time)
IMO (1 time)
2008 High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis.
18  hepatitis C virus core antigen
(2 times)
Botany
(1 time)
FBN (1 time)
GQD-SH (1 time)
PG (1 time)
2013 Dual targeting of a mature plastoglobulin/fibrillin fusion protein to chloroplast plastoglobules and thylakoids in transplastomic tobacco plants.
19  hepatitis C virus-positive
(2 times)
Epidemiology
(1 time)
CLD (1 time)
HR (1 time)
PEG-IFN (1 time)
1998 Systematic cutaneous examination in hepatitis C virus infected patients.
20  hepatitis type-C virus
(2 times)
Genetics
(1 time)
CI (1 time)
HRM (1 time)
OR (1 time)
2015 Identification of mutations in the HVR1 and PKR-BD regions in HCV-infected patients resistant to PEG-IFNalpha/RBV therapy.
21  high conservation value
(2 times)
Environmental Health
(2 times)
HCS (1 time)
POIG (1 time)
RSPO (1 time)
2015 Taking high conservation value from forests to freshwaters.
22  high-cholesterol plus vitamins C+E
(2 times)
Vascular Diseases
(2 times)
HC (2 times)
NC (2 times)
LDL (1 time)
2001 Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty.
23  HIV-hepatitis C
(2 times)
Patient Compliance
(1 time)
HIV (1 time)
IL-10 (1 time)
OR (1 time)
2010 Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV-HCV coinfected patients.
24  human chromosome vector
(2 times)
Genetics
(2 times)
--- 2001 Efficient male and female germline transmission of a human chromosomal vector in mice.
25  hybrid cooling vest
(2 times)
PAS (1 time)
PCMs (1 time)
PeSA (1 time)
2017 Hybrid cooling vest for cooling between exercise bouts in the heat: Effects and practical considerations.
26  anti-HCV
(1 time)
Gastroenterology
(1 time)
AIH (1 time)
AMA (1 time)
ANA (1 time)
1997 A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
27  Anti-hepatitis C virus positivity
(1 time)
Medicine
(1 time)
--- 1995 Anti-hepatitis C virus positivity (HCV) in Belgian volunteer blood donors: source of contamination and HCV-testing among donors and related recipients.
28  chronic C virus
(1 time)
Medicine
(1 time)
GGT (1 time)
IFN (1 time)
1999 [Therapy of chronic hepatitis C with alpha-interferon in 182 patients. Evaluation of results, response predictive factors and side effects].
29  Flaviviridae-hepatitis C virus
(1 time)
Epidemiology
(1 time)
HIV (1 time)
IVDU (1 time)
2001 HCV and GBV-c/HGV infection in HIV positive patients in southern Italy.
30  had pretransplant samples available for antihepatitis C virus
(1 time)
Transplantation
(1 time)
VOD (1 time)
1991 Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
31  had raised transaminases and positive antihepatitis C virus
(1 time)
Pediatrics
(1 time)
--- 1996 Lymphoblastoid interferon alfa treatment in chronic hepatitis C.
32  have revolutionised treatment for thehepatitis C virus
(1 time)
Health Services
(1 time)
DAAs (1 time)
2018 Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia.
33  have suggested that ribavirin may potentiate the antihepatitis C virus
(1 time)
Allergy and Immunology
(1 time)
IFN-alpha (1 time)
IL (1 time)
2001 Treatment with ribavirin and interferon-alpha reduces interferon-gamma expression in patients with chronic hepatitis C.
34  HCV and ALD for F1-2, F3 and F4
(1 time)
Gastroenterology
(1 time)
ALD (1 time)
LS (1 time)
2015 Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease.
35  HCV coinfected patients tend to develop hepatitis C
(1 time)
Allergy and Immunology
(1 time)
--- 2011 CXCR3 Expression Elevated on Peripheral CD8(+) Lymphocytes from HIV/HCV Coinfected Individuals.
36  HCV mono-infected
(1 time)
Allergy and Immunology
(1 time)
GrzB (1 time)
2015 Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype.
37  HCV pseudotypes VSVdeltaG
(1 time)
Allergy and Immunology
(1 time)
VSV (1 time)
2005 Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
38  HCV related cirrhosis
(1 time)
Neurology
(1 time)
HCC (1 time)
JCV (1 time)
PML (1 time)
2016 Progressive Multifocal Leukoencephalopathy in a HIV Negative, Immunocompetent Patient.
39  HCV-Hun
(1 time)
Complementary Therapies
(1 time)
--- 1993 [Molecular cloning and sequencing of hepatitis C virus gene from human blood].
40  HCV-O strain
(1 time)
Biochemistry
(1 time)
IFN (1 time)
sO (1 time)
2005 Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.
41  HCV-related
(1 time)
Substance-Related Disorders
(1 time)
CALD (1 time)
HBV (1 time)
2002 Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease.
42  HCV-titer
(1 time)
Substance-Related Disorders
(1 time)
ALD (1 time)
1993 Effects of alcohol on the replication of hepatitis C virus.
43  HCV-transmission, evidence is provided that TO.FE
(1 time)
Virology
(1 time)
--- 2007 Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro.
44  HCVcAg
(1 time)
Laboratory Techniques and Procedures
(1 time)
EIA (1 time)
2001 Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection.
45  HCVcc-Luc
(1 time)
Drug Therapy
(1 time)
DAAs (1 time)
2016 Evaluation of antiviral drug synergy in an infectious HCV system.
46  heel velocity
(1 time)
Nervous System Diseases
(1 time)
RCOF (1 time)
2013 Asymmetrical slip propensity: required coefficient of friction.
47  Hematocrit level
(1 time)
Clinical Medicine
(1 time)
NBT (1 time)
PV (1 time)
2015 The response of New-season Nile tilapia to Aeromonas hydrophila vaccine.
48  Hepacivirus
(1 time)
Chemistry
(1 time)
dsRNA (1 time)
2012 5-acetyl-2-arylbenzimidazoles as antiviral agents. Part 4.
49  heparin correlation value
(1 time)
Hospitals
(1 time)
APTT (1 time)
2011 Substitution of a heparin correlation value for activated partial thromboplastin time in heparin nomograms.
50  hepatic failure related to C virus
(1 time)
Microbiology
(1 time)
CT (1 time)
1997 Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis.
51  hepatitis A virus, C virus
(1 time)
Gastroenterology
(1 time)
ALT (1 time)
anti-HCV (1 time)
HBsAg (1 time)
1998 Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
52  hepatitis B and/or C viruses
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
CLD (1 time)
2006 Severe liver disease associated with prolonged exposure to antiretroviral drugs.
53  hepatitis C virus associated cirrhosis
(1 time)
Gastroenterology
(1 time)
ALc (1 time)
ALcW (1 time)
CC (1 time)
2011 Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.
54  Hepatitis C virus cases
(1 time)
Parasitology
(1 time)
CMIR (1 time)
1998 Cell mediated immune response in chronic liver diseases: schistosomal, viral and neoplastic.
55  hepatitis C virus cirrhosis
(1 time)
Transplantation
(1 time)
HCV Ab (1 time)
UNOS (1 time)
2006 No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data.
56  hepatitis C virus related chronic hepatitis
(1 time)
Pathology
(1 time)
CL (1 time)
2006 Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis.
57  Hepatitis C Virus seropositive
(1 time)
Brain
(1 time)
MDE (1 time)
2003 [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
58  hepatitis C-positive
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
CSAT (1 time)
2007 A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness.
59  hepatitis, is caused by a single-stranded RNA virus
(1 time)
Dentistry
(1 time)
--- 1996 Hepatitis C virus infection.
60  hepatocellular virus
(1 time)
Molecular Biology
(1 time)
DAB (1 time)
HCC (1 time)
2018 Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.
61  Hepatocellular volume
(1 time)
Medicine
(1 time)
EVA (1 time)
IHS (1 time)
SBA (1 time)
1988 Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.
62  hepatotropic viruses, especially hepatitis virus C
(1 time)
Substance-Related Disorders
(1 time)
HCC (1 time)
2003 National survey of hepatocellular carcinoma in heavy drinkers in Japan.
63  hepatotropic viruses, hepatitis B and hepatitis C
(1 time)
Neoplasms
(1 time)
HCC (1 time)
2006 Can therapy of hepatitis C affect the development of hepatocellular carcinoma?
64  high calorific value
(1 time)
Environmental Health
(1 time)
BMP (1 time)
FVW (1 time)
2018 Influence of chemical composition on biochemical methane potential of fruit and vegetable waste.
65  high case volume units
(1 time)
Gastrointestinal Diseases
(1 time)
LCV (1 time)
PUB (1 time)
2012 Management of peptic ulcer bleeding in different case volume workplaces: results of a nationwide inquiry in hungary.
66  High Contrast Visor
(1 time)
Aerospace Medicine
(1 time)
LEP (1 time)
SWAFs (1 time)
2000 Aircrew visors and color vision performance: a comparative and preliminary pilot study analysis.
67  high contrast volume
(1 time)
Complementary Therapies
(1 time)
CI-AKI (1 time)
CKD (1 time)
MCV (1 time)
2015 Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
68  High-context-variability
(1 time)
Psychology
(1 time)
LCV (1 time)
2006 The effect of context variability on source memory.
69  high-cyanide cultivar
(1 time)
Physiology
(1 time)
--- 2002 Linamarase expression in cassava cultivars with roots of low- and high-cyanide content.
70  HIV mono- and co-infected and hepatitis
(1 time)
Endocrinology
(1 time)
IDUs (1 time)
2015 Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.
71  hollow cylinder volume
(1 time)
Ecological and Environmental Phenomena
(1 time)
De (1 time)
HA (1 time)
HR (1 time)
2017 Internode morphometrics and allometry of Tonkin Cane Pseudosasa amabilis.
72  holocinematographic velocimeter
(1 time)
Ophthalmology
(1 time)
--- 1987 Holocinematographic velocimetry: resolution limitation for flow measurement.
73  Holographic Correlation Velocimetry
(1 time)
Medicine
(1 time)
--- 2013 Optimisation of a stirred bioreactor through the use of a novel holographic correlation velocimetry flow measurement technique.
74  home care ventilators
(1 time)
Thoracic Diseases
(1 time)
PEEP (1 time)
VC (1 time)
VT (1 time)
2016 A bench evaluation of fraction of oxygen in air delivery and tidal volume accuracy in home care ventilators available for hospital use.
75  hospital case volume
(1 time)
Neoplasms
(1 time)
HVI (1 time)
IMRT (1 time)
LRPFS (1 time)
2018 The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106).
76  housing choice voucher
(1 time)
Geriatrics
(1 time)
--- 2016 Differential Health and Social Needs of Older Adults Waitlisted for Public Housing or Housing Choice Vouchers.
77  HRV, three coronavirus
(1 time)
Allergy and Immunology
(1 time)
ICAM-1 (1 time)
PI (1 time)
RSV (1 time)
1996 Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals.
78  Human C virus
(1 time)
Pediatrics
(1 time)
ALT (1 time)
IFN-alpha (1 time)
2003 Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C.
79  human candidate calicivirus
(1 time)
Virology
(1 time)
--- 1984 Propagation of human candidate calicivirus in cell culture.
80  human coronaviruses strain
(1 time)
Neurology
(1 time)
AMON (1 time)
MS (1 time)
1999 Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis.
81  human CV
(1 time)
Biology
(1 time)
CV (1 time)
TCR (1 time)
1995 Characterization of human T cell clones specific for coronavirus 229E.
82  human immune globulins made from antihepatitis C virus
(1 time)
Science
(1 time)
--- 2009 Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.
83  human respiratory coronavirus
(1 time)
Virology
(1 time)
--- 1983 Clones of MRC-C cells may be superior to the parent line for the culture of 229E-like strains of human respiratory coronavirus.
84  Hybrid cell vaccine
(1 time)
Allergy and Immunology
(1 time)
CTL (1 time)
IL-10 (1 time)
IL-4 (1 time)
2007 Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.
85  Hypercellularity volume
(1 time)
Neoplasms
(1 time)
DWI (1 time)
GB (1 time)
MRI (1 time)
2015 Hypercellularity Components of Glioblastoma Identified by High b-Value Diffusion-Weighted Imaging.
86  hypercholesterolemic vodka
(1 time)
General Surgery
(1 time)
HCC (1 time)
HCW (1 time)
2016 Alcohol modulates autophagy and apoptosis in pig liver tissue.
87  inducible-hepatitis C virus
(1 time)
Virology
(1 time)
Ad-pIX (1 time)
AdV (1 time)
Cre (1 time)
2011 Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirus.
88  structure-anti-hepatitis C virus
(1 time)
Chemistry
(1 time)
--- 2005 Synthesis and structure-activity relationships of novel anti-hepatitis C agents: N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one derivatives.
89  virus--Hepatitis C Virus
(1 time)
Gastroenterology
(1 time)
--- 1990 [Antibodies against hepatitis C virus in patients with liver diseases and in risk subjects. Preliminary report].
90  wash contained viral nucleic acid
(1 time)
Communicable Diseases
(1 time)
HBV (1 time)
PCR (1 time)
2006 A prospective study of the efficacy of routine decontamination for gastrointestinal endoscopes and the risk factors for failure.